112 related articles for article (PubMed ID: 31072725)
21. Increased risk of neuroectodermal tumors and stomach cancer in relatives of patients with Ewing's sarcoma family of tumors.
Novakovic B; Goldstein AM; Wexler LH; Tucker MA
J Natl Cancer Inst; 1994 Nov; 86(22):1702-6. PubMed ID: 7966398
[TBL] [Abstract][Full Text] [Related]
22. Translocation (11;22) in Ewing's sarcoma.
Prieto F; Badía L; Montalar J; Massuti B
Cancer Genet Cytogenet; 1985 May; 17(1):87-9. PubMed ID: 3986752
[TBL] [Abstract][Full Text] [Related]
23. Primary skeletal Ewing's sarcoma in Down syndrome.
Bridge JA; Neff JR; Borek DA; Hackbarth DA
Cancer Genet Cytogenet; 1990 Jul; 47(1):61-8. PubMed ID: 2141543
[TBL] [Abstract][Full Text] [Related]
24. Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report.
Fujii H; Honoki K; Enomoto Y; Kasai T; Kido A; Amano I; Kumamoto M; Morishita T; Mii Y; Nonomura A; Takakura Y
Virchows Arch; 2006 Nov; 449(5):579-84. PubMed ID: 17016721
[TBL] [Abstract][Full Text] [Related]
25. MDM2 and CDK4 gene amplification in Ewing's sarcoma.
Ladanyi M; Lewis R; Jhanwar SC; Gerald W; Huvos AG; Healey JH
J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717
[TBL] [Abstract][Full Text] [Related]
26. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Fuchs B; Inwards C; Scully SP; Janknecht R
Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
[TBL] [Abstract][Full Text] [Related]
27. Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcoma.
Park YK; Chi SG; Kim YW; Park HR; Unni KK
Oncol Rep; 1999; 6(6):1261-6. PubMed ID: 10523693
[TBL] [Abstract][Full Text] [Related]
28. The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue.
Granowetter L; West DC
Cancer Treat Res; 1997; 92():253-308. PubMed ID: 9494764
[No Abstract] [Full Text] [Related]
29. Overexpression of miR‑199b‑5p inhibits Ewing's sarcoma cell lines by targeting CCNL1.
Li W; Li Y; Guo J; Pan H; Zhang Y; Wang X
Mol Med Rep; 2015 Sep; 12(3):3359-3364. PubMed ID: 26043836
[TBL] [Abstract][Full Text] [Related]
30. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.
Parafioriti A; Bason C; Armiraglio E; Calciano L; Daolio PA; Berardocco M; Di Bernardo A; Colosimo A; Luksch R; Berardi AC
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144561
[TBL] [Abstract][Full Text] [Related]
31. Neurogenic potential of Ewing's sarcoma cells.
Sugimoto T; Umezawa A; Hata J
Virchows Arch; 1997 Jan; 430(1):41-6. PubMed ID: 9037314
[TBL] [Abstract][Full Text] [Related]
32. Scanning and transmission electron microscopy of Ewing's sarcoma of bone (typical and atypical variants). An analysis of nine cases.
Llombart-Bosch A; Peydro-Olaya A
Virchows Arch A Pathol Anat Histopathol; 1983; 398(3):329-46. PubMed ID: 6402843
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
35. Ewing's sarcoma oncogene structure: a novel prognostic marker?
Fletcher JA
J Clin Oncol; 1998 Apr; 16(4):1241-3. PubMed ID: 9552020
[No Abstract] [Full Text] [Related]
36. Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.
Yan C; Wang Y; Wang Q; Feng X; Wang L; Bu Z; Lu B; Jiang J
J BUON; 2018; 23(5):1472-1480. PubMed ID: 30570875
[TBL] [Abstract][Full Text] [Related]
37. Potential approaches to the treatment of Ewing's sarcoma.
Yu H; Ge Y; Guo L; Huang L
Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
[TBL] [Abstract][Full Text] [Related]
38. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).
Turc-Carel C; Aurias A; Mugneret F; Lizard S; Sidaner I; Volk C; Thiery JP; Olschwang S; Philip I; Berger MP
Cancer Genet Cytogenet; 1988 Jun; 32(2):229-38. PubMed ID: 3163261
[TBL] [Abstract][Full Text] [Related]
39. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
40. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
